Medpage Today -- Patients with arthritis taking a COX-2 selective nonsteroidal anti-inflammatory drug (NSAID) appear to have a lower risk of adverse gastrointestinal events compared with those on a nonselective NSAID plus a proton-pump inhibitor (PPI), a large international trial found.
